Quantum-SiQSI
QSI logo
Fair Value
US$2.68
Share price24 Dec
US$0.8867.1% undervalued intrinsic discount
Loading
1Y-48.98%
7D-5.13%

Single Molecule Protein Sequencing Platforms Will Drive Long Term Proteomics Demand Narrative

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
24 Dec 25
Views
31
Not Invested

Fair Value vs Share Price

US$2.68
vs US$0.8867.1% undervalued intrinsic discount
PastFuture-132m43m201920212023202520272028Revenue US$42.7mEarnings US$6.7m
137.7%
Revenue growth
15.7%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Quantum-Si

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Flawless balance sheet with slight risk.

Market capUS$192.2m
PB1.0x
Estimated Growth63.8%
Dividend YieldN/A
Full analysis

CEO & management

Jeffrey Hawkins
CEO
3.5yrs
CEO Tenure

A life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS).